Predictive value of PIMREG in the prognosis and response to immune checkpoint blockade of glioma patients.

导出 LinkOut

翻译打印收藏纠错

作者： Hua,Zhu ^[1] ; Xinyao,Hu ^[2] ; Shi,Feng ^[3] ; Lijuan,Gu ^[1] ; Zhihong,Jian ^[4] ; Ning,Zou ^[1] ; Xiaoxing,Xiong ^[5]

作者单位： Department of Neurosurgery, Renmin Hospital of Wuhan University, Wuhan, China. ^[1] Department of Neurosurgery, The Affiliated Huzhou Hospital, Zhejiang University School of Medicine (Huzhou Central Hospital), Huzhou, China. ^[2] Cancer Center, Renmin Hospital of Wuhan University, Wuhan, China. ^[3] Central Laboratory, Renmin Hospital of Wuhan University, Wuhan, China. ^[4] Department of Radiation Oncology, Hubei Cancer Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China. ^[5]

关键词 PIMREG glioma immune cell infiltrates immune checkpoint immune checkpoint blockade (ICB) therapy

主题词脑肿瘤(Brain Neoplasms);神经胶质瘤(Glioma);人类(Humans);肿瘤复发, 局部(Neoplasm Recurrence, Local);预后(Prognosis)

DOI 10.3389/fimmu.2022.946692

PMID 35928818

发布时间 2022-08-24

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交